Company intelligence / Profile preview

Vesalius Biocapital III

Bertrange or Strassen area, Luxembourg

Ownership: Private
Employees: ~5
Development stage: Other

Overview

Vesalius Biocapital III is a European life sciences venture capital fund of about €120 million that invests in later-stage companies in drug development, medical devices & diagnostics, and eHealth/mHealth, predominantly in Europe. It is managed by Vesalius Biocapital Partners and received a €30 million cornerstone investment from the European Investment Fund.

Industry: Investors

Partnerships

European Investment Fund (EIF) – €30 million investment as a limited partner in Vesalius Biocapital III

Beyond the preview

Go deeper on Vesalius Biocapital III.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Vesalius Biocapital III.

Explore the full profile